SUN'iy intellekt yordamida ko'krak bezi saratoniga tashhis qo'yish: HOZIRGI TADQIQOTLAR VA ILMIY YANGILIKLAR
Abstrak
Ko'krak bezi saratoni butun dunyo bo'ylab ayollarda eng ko'p uchraydigan xavfli kasallik bo'lib qolmoqda,
diagnostika aniqligini oshirish uchun sun'iy intellektga (AI) katta qiziqish uyg'otdi va
samaradorlik. Ushbu maqolada o'rnatilgan klinik AI vositalari va ilg'or tadqiqotlar ko'rib chiqiladi
ko'krak bezi saratoni diagnostikasi bo'yicha ishlanmalar, diqqat markazida Qo'shma Shtatlar (AQSh), Buyuk Britaniya
(Buyuk Britaniya) va Markaziy Osiyo (O‘zbekiston va Tojikiston). Biz hozirgi sun'iy intellekt yordamida diagnostikani belgilaymiz
tasvirlashda, xususan, mammografiyada, klinik foydalanishda, shu jumladan
FDA tomonidan tasdiqlangan qarorlarni qo'llab-quvvatlash tizimlari va ularning sog'liqni saqlash amaliyotida o'zgaruvchan qabul qilinishini muhokama qiling.
2022–2025 yillardagi soʻnggi yutuqlar, masalan, mos keladigan chuqur oʻrganish modellari taʼkidlangan.
AI tomonidan boshqariladigan tasvirlashda ko'krak bezi saratonini aniqlashda rentgenologning ko'rsatkichlaridan oshib ketdi
xavfni bashorat qilish modellari va o'simtalarni tasniflash va metastaz uchun raqamli-patologiya algoritmlari
aniqlash. Shuningdek, biz mintaqaviy tashabbuslarni ko'rib chiqamiz: Buyuk Britaniyada AIni integratsiyalashgan yirik istiqbolli sinovlar
milliy skriningga, AQSHda joylashtirish va me'yoriy tasdiqlashlar va AIni joriy etish harakatlari
Resurs cheklovlari sharoitida O‘zbekiston sog‘liqni saqlash tizimida diagnostika. Katta ma'lumotlarning roli
Katta izohli ma'lumotlar to'plami va ko'p markazli hamkorlik ushbu AIni ishga tushirgani ta'kidlangan.
innovatsiyalar. Qiyinchiliklar, jumladan, ma'lumotlar sifati, noaniqlik, klinik ish oqimlariga integratsiya va
Markaziy Osiyoda mahalliy salohiyatga ehtiyoj – muhokama qilinadi. Umuman olganda, AI tomonidan boshqariladigan vositalar tayyor
ko'krak bezi saratoni skriningi va diagnostikasini kuchaytirish, ayniqsa sharoitlarda erta aniqlashni yaxshilash
cheklangan mutaxassislar bilan, davom etayotgan tadqiqot va sinovlar esa ularning xavfsizligini yaxshilash va
samaradorlik.
References
Eisemann N., Bunk S., Mukama T., et al. (2025). “Nationwide real-world implementation of AI for cancer detection in population-based mammography screening.” Nature Medicine, 31:917–924nature.comnature.com.
Venkatesan P. (2025). “Largest trial of AI in breast cancer screening launched.” Lancet Oncology, 26(3): e120 thelancet.com.
Campbell D. (2025). “NHS to launch world’s biggest trial of AI breast cancer diagnosis.” The Guardian, Feb 4, 2025 theguardian.comtheguardian.com.
Lång K., et al. (2023). “AI-supported screen reading vs standard double reading in screening (MASAI trial).” Lancet Oncology, 24(8): 1020–1030. (Preliminary results: AI increased detection by 20%, no increase in false positives, 44% workload reduction euronews.comeuronews.com.)
McKinney S.M., Mutasa S., Sieniek M., et al. (2020). “International evaluation of an AI system for breast cancer screening.” Nature, 577:89–94nature.com. (AI reduced false negatives by 9.4% in the US dataset and false positives by 5.7% nature.com.)
Taylor C.R., Monga N., Johnson C., et al. (2023). “Artificial Intelligence Applications in Breast Imaging: Current Status and Future Directions.” Diagnostics (Basel), 13(12):2041 mdpi.commdpi.com.
Dur Karasayar A.H., Kulaç İ., Kapucuoğlu N., et al. (2025). “Advances in Breast Cancer Care: The Role of Artificial Intelligence and Digital Pathology in Precision Medicine.” European Journal of Breast Health, 21(3): 230–242pmc.ncbi.nlm.nih.govpmc.ncbi.nlm.nih.gov.
Rim J.S., Tillyashaikhov M., Park B., et al. (2022). “Comparison of Breast Cancer and Cervical Cancer in Uzbekistan and Korea: The First Report of the Uzbekistan–Korea Oncology Consortium.” Medicina, 58(11):1524. (Reported common stages II–III for breast cancer in Uzbekistan and need for national screening efforts pmc.ncbi.nlm.nih.gov pmc.ncbi.nlm.nih.gov.)
Euronews – Smart Health (2023). “AI has helped radiologists detect 20% more cases of breast cancer during screenings, new study finds.” Lauren Chadwick, Aug 2, 2023 euronews.comeuronews.com. (Coverage of Swedish trial showing AI + radiologist detected more cancers with no increase in false positives.)
Downloads
Nashr qilingan
Nashr
Bo'lim
License
Copyright (c) 2025 Mukhitdinova Manzura Avazbek qizi
This work is licensed under a Creative Commons Attribution 4.0 International License.
(+998)90 142-39-38
Andijon viloyati, Marhamat tumani, Qashqar ko’chasi 189-uy